Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications.

Rahman, Rifaquat

Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 11 2019 - 6339-6345 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-18-3999 doi


Clinical Trials, Phase III as Topic--standards
Humans
Immunotherapy--standards
Kaplan-Meier Estimate
Neoplasms--drug therapy
Precision Medicine--standards
Proportional Hazards Models
Randomized Controlled Trials as Topic--standards